The Annals of Internal Medicine published a guideline, entitled “The Standard Protocol Items: Recommendations for Interventional Trials” or SPIRIT 2013 to address the clinical practice quality issues surrounding current trials, as reported by an article on...
A recent article from mobihealthnews.com describes how technology is helping streamline clinical trials by bridging communication between investigators, pharmaceutical companies and participants. Communication between companies and third party investigators is often a...
A recent post from MedPage Today describes the newly published FDA draft guidance entitled “Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products” that will potentially improve the speed of drug development. The guidance...
Huron Life Sciences recently released an article about a recent pilot study conducted by National Cancer Institute (NCI). During the month of October, The NCI conducted a pilot study testing feasibility of using an independent CIRB model. Twenty- four institutions...
Ken Getz, assistant professor at Tufts Center for the Study of Drug Development (CSDD), reports that oftentimes procedures performed in the last drug development stages are in order to find “supplementary, secondary, tertiary, and exploratory endpoints.”...
